Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma

doi:10.4251/wjgo.v16.i6.2476

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1379)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

HTML

812

Figures (1-5)

118

Tables (1-4)

107

Sum=1068

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

205

Sum=267

Jun 15, 2024 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2476-2486
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2476

Full Size Figure Download Figure

Figure 3 Kaplan-Meier analysis of survival outcomes in patients. A: Recurrence-free survival comparisons; B: Overall diameter of target tumors; C: Alpha-fetoprotein level before liver transplantation; D: Macrovascular invasion. DEB-TACE: Drug-eluting bead transcatheter arterial chemoembolization; AFP: Alpha-fetoprotein; LT: Liver transplantation.

Citation: Ye ZD, Zhuang L, Song MC, Yang Z, Zhang W, Zhang JF, Cao GH. Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(6): 2476-2486
URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2476.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2476